UCB4594

Cancer Research UK · Phase 1 active Small molecule

At a glance

Generic name	UCB4594
Sponsor	Cancer Research UK
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

A Phase I/II Trial of UCB4594 in Participants With Advanced Cancer (PHASE1, PHASE2)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

UCB4594 CI brief — competitive landscape report
UCB4594 updates RSS · CI watch RSS
Cancer Research UK portfolio CI